Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug
Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug
Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug
Submitted by
admin
on February 19, 2014 - 9:26am
Source:
Yahoo/Zacks.com
News Tags:
Regeneron
Eylea
Gilead Sciences
ledipasvir
Sovaldi
hepatitis C
Cangrelor
The Medicines Company
Headline:
Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug
Do Not Allow Advertisers to Use My Personal information
